Sumatriptan Succinate Tablet, Film Coated
Product Images NDC 51407-012

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 51407-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Structural Formula (Image 01)

Chemical structure of sumatriptan succinate, depicting the molecular arrangement of atoms including an indole ring, sulfonamide group, and succinate moiety.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Image 02)

A line graph showing the Estimated Probability of Response over Time in Minutes from Initial Dose for placebo and sumatriptan succinate tablets at 25 mg, 50 mg, and 100 mg doses. The graph illustrates increasing response probabilities over 240 minutes, with higher doses generally showing greater response.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Image 03)

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for Sumatriptan Succinate tablets at 25 mg, 50 mg, and 100 mg strengths compared to placebo. The graph depicts increasing probabilities over a 24-hour period, with placebo having the highest probability, followed by 25 mg, 50 mg, and 100 mg doses.*

FDA Label Image

51407-011-09lb- Rev 04-24.jpg (51407 011 09lb Rev 04 24)

Sumatriptan Succinate 25 mg film-coated tablets label from Golden State Medical Supply, Inc., containing 9 tablets. The label includes the NDC 51407-011-09 and dosage instructions, along with storage conditions and safety warnings. It instructs pharmacists to dispense patient information and lists the manufacturer's location in Camarillo, CA.*

FDA Label Image

51407-012-09lb- Rev 04-24.jpg (51407 012 09lb Rev 04 24)

Label for SUMAtriptan Tablets USP 50 mg film-coated tablets by Golden State Medical Supply, Inc. The package contains 9 tablets. The label includes dosage strength, NDC 51407-012-09, pharmacist instructions to dispense patient information, storage conditions, safety warnings, and a barcode.*

FDA Label Image

51407-013-09lb- Rev 04-24.jpg (51407 013 09lb Rev 04 24)

Label for Sumatriptan 100 mg film-coated tablets, USP by Golden State Medical Supply, Inc. The label states the NDC number 51407-013-09 and notes each tablet contains 140 mg of sumatriptan succinate, equivalent to 100 mg of sumatriptan. The package contains 9 tablets, prescription only. Instructions include swallowing tablets whole with water and storing in a tight, light-resistant container at controlled room temperature. The label also provides a URL for patient information and cautions to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.